Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Aging

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2013.12.031PMID 24468471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease

  2013cited by this paper
• Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.

  2013cited by this paper
• Synaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy

  2013cited by this paper
• Tetrahydrohyperforin Decreases Cholinergic Markers associated with Amyloid-β Plaques, 4-Hydroxynonenal Formation, and Caspase-3 Activation in AβPP/PS1 Mice

  2013cited by this paper
• A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

  2012influential reference
• Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease

  2012cited by this paper
• Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis

  2012influential reference
• The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.

  2011cited by this paper
• The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats.

  2011influential reference
• Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative‐induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy

  2011cited by this paper
• Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats.

  2011cited by this paper
• Targeting the neurovascular unit: development of a new model and consideration for novel strategy for Alzheimer's disease.

  2011influential reference
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011influential reference
• The Flavonoid Apigenin Protects Brain Neurovascular Coupling against Amyloid-β25-35-Induced Toxicity in Mice

  2011influential reference
• Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

  2011cited by this paper
• RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

  2010cited by this paper
• Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

  2010cited by this paper
• Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats

  2010influential reference
• Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

  2009cited by this paper
• RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

  2009cited by this paper
• Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.

  2009cited by this paper
• Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

  2008cited by this paper
• New therapeutic targets in the neurovascular pathway in Alzheimer’s disease

  2008influential reference
• Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro.

  2008cited by this paper
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

  2008influential reference
• Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.

  2007cited by this paper
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2007cited by this paper
• Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages.

  2006influential reference
• Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats.

  2006cited by this paper
• Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.

  2006cited by this paper
• The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

  2005cited by this paper
• RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair

  2005influential reference
• Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

  2005influential reference
• Neurovascular mechanisms of Alzheimer's neurodegeneration.

  2005influential reference
• LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

  2004cited by this paper
• Regulation of tight junctions and loss of barrier function in pathophysiology.

  2004cited by this paper
• NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models

  2004influential reference
• Neurovascular regulation in the normal brain and in Alzheimer's disease

  2004cited by this paper
• APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease.

  2004cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003influential reference
• Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model

  2003cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

  2002cited by this paper
• Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging.

  2002cited by this paper
• Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage

  1999cited by this paper
• Brain inflammation in Alzheimer disease and the therapeutic implications.

  1999cited by this paper
• Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.

  1997cited by this paper
• Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous System.

  1997cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• A morphometric study of the blood-brain barrier in Alzheimer's disease.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Kinetics of arginine-vasopressin uptake at the blood-brain barrier.

  1990cited by this paper
• Kinetic Analysis of Leucine‐Enkephalin Cellular Uptake at the Luminal Side of the Blood‐Brain Barrier of an In Situ Perfused Guinea‐Pig Brain

  1989cited by this paper
• Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).

  1985cited by this paper
• Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone.

  1985cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Cytotoxicity and molecular mechanisms of quercetin, gallic acid, and pinocembrin in Caco-2 cells: insights from cell viability assays, network pharmacology, and molecular docking

  2025cites this paper
• Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.

  2025cites this paper
• A Straightforward Synthesis of Pinocembrin.

  2025cites this paper
• Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies

  2024cites this paper
• Mechanistic and Therapeutic Insights into Flavonoid-Based Inhibition of Acetylcholinesterase: Implications for Neurodegenerative Diseases

  2024cites this paper
• Deciphering the multi-functional role of Indian propolis for the management of Alzheimer’s disease by integrating LC–MS/MS, network pharmacology, molecular docking, and in-vitro studies

  2024cites this paper
• Exploring the Therapeutic Potential of BBB‐Penetrating Phytochemicals With p38 MAPK Modulatory Activity in Addressing Oxidative Stress‐Induced Neurodegenerative Disorders, With a Focus on Alzheimer's Disease

  2024cites this paper
• The phenylpropionamide extract of hemp (Cannabis sativa L.) seed improves learning memory ability and survival rate by attenuating microglia activation? and reducing amyloid deposition via the SIRT1-AMAD10 pathway in APP/PS1 mice

  2024cites this paper
• Exploring the Therapeutic Potential of Glycyrrhiza Compounds in Alzheimer's Disease: A Comprehensive Review.

  2024cites this paper
• Pinocembrin alleviates LPS-induced depressive-like behavior in mice via the NLRP3/DCC signaling pathway.

  2024cites this paper
• CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities

  2023cites this paper
• EN PRENSA. Efecto antioxidante de polifenoles presentes en bagazo residual de orégano mexicano (Lippia graveolens Kunth) en aceite vegetal de girasol.EN PRENSA

  2023cites this paper
• Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2023cites this paper
• Engineered living materials for the conversion of a low-cost food-grade precursor to a high-value flavonoid

  2023cites this paper
• Polyphenols Targeting MAP Kinase Signaling Pathway in Neurological Diseases: Understanding Molecular Mechanisms and Therapeutic Targets

  2023cites this paper
• Therapeutic benefits of flavonoids against neuroinflammation: a systematic review

  2022cites this paper
• Pinocembrin Relieves Mycoplasma pneumoniae Infection‑Induced Pneumonia in Mice Through the Inhibition of Oxidative Stress and Inflammatory Response

  2022cites this paper
• Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches

  2022cites this paper
• Mapping review of the potential of Tarap Plants (Artocarpus odoratissimus) for health

  2022cites this paper
• Pinocembrin Decreases Atrial Fibrillation Susceptibility in a Rodent Model of Depression

  2022cites this paper
• Pinocembrin ameliorates atrial fibrillation susceptibility in rats with anxiety disorder induced by empty bottle stimulation

  2022cites this paper
• Valorización del bagazo residual de orégano mexicano (Lippia graveolens HBK) mediante la obtención de fracciones enriquecidas en pinocembrina

  2022cites this paper
• Pinocembrin Ameliorates Neuronal Cell Death by Regulating Autoimmune Signals

  2022cites this paper
• Pinocembrin mediates antiarrhythmic effects in rats with isoproterenol-induced cardiac remodeling.

  2022cites this paper
• Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders

  2021cites this paper
• Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure

  2021cites this paper
• Pinocembrin Promotes OPC Differentiation and Remyelination via the mTOR Signaling Pathway

  2021cites this paper
• Propolis ve Sağlık Üzerine Etkileri

  2021cites this paper
• Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway

  2021cites this paper
• Experimental Evidence for Therapeutic Potentials of Propolis

  2021cites this paper
• Bee Products: A Representation of Biodiversity, Sustainability, and Health

  2021cites this paper
• Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future

  2021cites this paper
• Propolis Extract and Its Bioactive Compounds—From Traditional to Modern Extraction Technologies

  2021cites this paper
• A Brief Review of Alzheimer’s Disease

  2021cites this paper
• Protective and therapeutic effects of the flavonoid “pinocembrin” in indomethacin-induced acute gastric ulcer in rats: impact of anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms

  2021cites this paper
• Pinocembrin Reduces Arthritic Symptoms in Mouse Model via Targeting Sox4 Signaling Molecules

  2021cites this paper
• Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation

  2021cites this paper
• Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review.

  2021cites this paper
• Pinocembrin Ameliorates Cognitive Impairment Induced by Vascular Dementia: Contribution of Reelin-dab1 Signaling Pathway

  2020cites this paper
• Phytochemical study and antioxidant activity of Dalbergia ecastaphyllum

  2020cites this paper
• Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action

  2020cites this paper
• Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of Depression

  2020cites this paper
• DDDT_A_249176 3577..3587

  2020cites this paper
• Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases

  2020cites this paper
• Prostaglandins and Other Lipid Mediators

  2019influential citation
• Biological Evaluation and Docking Analysis of Potent BACE1 Inhibitors from Boesenbergia rotunda

  2019cites this paper
• 7-Pyrrolidinethoxy-4′-Methoxyisoflavone Prevents Amyloid β–Induced Injury by Regulating Histamine H3 Receptor-Mediated cAMP/CREB and AKT/GSK3β Pathways

  2019cites this paper
• Spherical and tubular dimyristoylphosphatidylcholine liposomes

  2019cites this paper
• Advances in Biosynthesis, Pharmacology, and Pharmacokinetics of Pinocembrin, a Promising Natural Small-Molecule Drug

  2019cites this paper
• Pinocembrin Protects Against Dextran Sulfate Sodium-Induced Rats Colitis by Ameliorating Inflammation, Improving Barrier Function and Modulating Gut Microbiota

  2019cites this paper
• Comparison between the vapor-phase-mediated anti-Candida activity of conventional and organic essential oils

  2019cites this paper
• Antiviral activity of pinocembrin against Zika virus replication.

  2019cites this paper
• Prostaglandins and Other Lipid Mediators Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

  2019cites this paper
• Evidence on the Health Benefits of Supplemental Propolis

  2019cites this paper
• The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol

  2019cites this paper
• Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin

  2019cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration.

  2018cites this paper
• Long-Term DL-3-n-Butylphthalide Treatment Alleviates Cognitive Impairment Correlate With Improving Synaptic Plasticity in SAMP8 Mice

  2018cites this paper
• Total flavonoid extract from Dracoephalum moldavica L. attenuates &bgr;‐amyloid‐induced toxicity through anti‐amyloidogenesic and neurotrophic pathways

  2018cites this paper
• Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Solid state fermentation of pomegranate husk: Recovery of ellagic acid by SEC and identification of ellagitannins by HPLC/ESI/MS

  2018cites this paper
• The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer’s Disease

  2018cites this paper
• Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice.

  2018influential citation
• Major volatile compounds in the essential oil of the aromatic culinary herb Pelargonium crispum (Geraniaceae)

  2018cites this paper
• Neuroprotective effects of phytosterol esters against high cholesterol-induced cognitive deficits in aged rat.

  2017cites this paper
• Pinocembrin Suppresses H2O2-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells

  2017cites this paper
• Using functional and molecular MRI techniques to detect neuroinflammation and neuroprotection after traumatic brain injury.

  2017cites this paper
• Protective effects of the Sophorae Fructus on cognitive impairment and neuroinflammatory alteration in an Aβ1-42-infused Alzheimer’s disease mouse model

  2017cites this paper
• Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways

  2017cites this paper
• Biological properties of propolis extracts: Something new from an ancient product.

  2017influential citation
• Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation.

  2017cites this paper
• The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review

  2017cites this paper
• YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice

  2017cites this paper
• Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia.

  2017cites this paper
• Immunopathology of the Nervous System

  2017cites this paper
• Isolation and synthesis of pinocembrin and pinostrobin from Artocarpus odoratissimus.

  2017cites this paper
• Role of RAGE in Alzheimer’s Disease

  2016cites this paper
• Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1 pathway in SH-SY5Y cells.

  2016cites this paper
• Stepwise modular pathway engineering of Escherichia coli for efficient one-step production of (2S)-pinocembrin.

  2016cites this paper
• Glial-endothelial crosstalk regulates blood-brain barrier function.

  2016cites this paper
• Pinocembrin attenuates MPP(+)-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway.

  2016cites this paper
• The Natural Flavonoid Pinocembrin: Molecular Targets and Potential Therapeutic Applications

  2016cites this paper
• Transcriptome-enabled discovery and functional characterization of enzymes related to (2S)-pinocembrin biosynthesis from Ornithogalum caudatum and their application for metabolic engineering

  2016influential citation
• Synthesis and biological evaluation of 5,7-dihydroxyflavanone derivatives as antimicrobial agents.

  2016cites this paper
• The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

  2016cites this paper
• Phenolic profile, antioxidant activity and enzyme inhibitory activities of extracts from aromatic plants used in Mediterranean diet

  2016cites this paper
• Modulation of neurotrophic signaling pathways by polyphenols

  2015cites this paper
• The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease

  2015cites this paper
• Focusing on metabolomic dysregulation and modulation of retinal metabolism to develop novel therapeutic strategies for diabetic retinopathy

  2015cites this paper
• Alzheimer’s disease therapies: Selected advances and future perspectives

  2015cites this paper
• Neuroprotective effect from stem bark extracts of Knema laurina against H2O2- and Aβ1–42-induced cell death in human SH-SY5Y cells

  2015cites this paper
• Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

  2015cites this paper
• Antiacetylcholinesterase and Cytotoxic Activities of Egyptian Propolis with Correlation to its GC / MS and HPLC Analysis

  2015cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

  2014cites this paper
• Vascular and glial alterations during aging in wild-type mice and along Alzheimer's disease progression in APP/PS1 mice

  2014cites this paper
• Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats

  2014cites this paper
• SHORT COMMUNICATION Neuroprotective effect from stem bark extracts of Knema laurina against H2O2- and Ab1-42-induced cell death in human SH-SY5Y cells

  2014cites this paper
• Pinocembrin Protects Human Brain Microvascular Endothelial Cells against Fibrillar Amyloid-β 1−40Injury by Suppressing the MAPK/NF-κB Inflammatory Pathways

  2014cites this paper
• RAGE Inhibition in Microglia Prevents Ischemia-Dependent Synaptic Dysfunction in an Amyloid-Enriched Environment

  2014cites this paper